Study of fibrinopeptide A, fibrin monomer and fibrin degradation products in non-insulin dependent diabetes mellitus
Journal of the Egyptian Society of Endocrinology, Metabolism and Diabetes [The]. 1990; 22 (1): 153-171
in English
| IMEMR
| ID: emr-145602
ABSTRACT
The study was carried out on 20 non-insulin dependent diabetics and 10 healthy adult control subjects. The work aimed at estimation of fibrinopeptide A [FPA], fibrin monomer [FM] and fibrin degradation products [FDP] in non-insulin dependent diabetic patients with and without vascular complications, in addition to euglobulin clot lysis time [EGCLT], blood sugar, serum triglycerides, serum cholesterol, HDL-cholesterol and LDL-cholesterol. Serum fibrinopeptide-A [FPA] level was elevated in diabetics with vascular complications, reflecting augmented thrombin activity. EGCLT showed significant prolongation in diabetics with vascular complications. Pathological levels of FDP were detected in three diabetic patients [30%] with vascular complications. The significance of these findings were then analyzed and discussed
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Triglycerides
/
Fibrin Fibrinogen Degradation Products
/
Fibrinopeptide A
/
Serum Globulins
/
Cholesterol
Limits:
Female
/
Humans
/
Male
Language:
English
Journal:
J. Egypt. Soc. Endocrinol. Metab. Diabetes
Year:
1990
Similar
MEDLINE
...
LILACS
LIS